Using the Global Health Sector Strategy and its 2025 targets to drive change 

World Health Organization’s (WHO) new Global Health Sector Strategy (GHSS) on HIV, viral hepatitis and sexually transmitted infections (STIs) promotes the disease specific goals to end AIDS and the epidemics of viral hepatitis and STIs by 2030. The new strategies propose a common vision to end epidemics and advance universal health coverage, primary health care and health security in a world where all people have access to high-quality, evidence-based and people-centered health services.  

The new GHSS sets out interim 2025 targets that countries will need to work towards. With less than three years till these interim targets and eight years until the 2030 targets, most countries must accelerate their efforts to achieve them.  

Resource toolkit for community organisations

We have developed a brief toolkit to summarise what the GHSS means for civil society and community organisations and equip them to use the GHSS as a tool to support advocacy efforts and drive hepatitis-related policies.  

As part of this, we have provided a template letter, co-signed by WHA, for civil society and community organisations to adapt and use to engage their health ministers and governments. 


Watch our webinar: Hepatitis Can’t Wait: Using the Global Health Sector Strategy and its 2025 targets to drive change. 

We were joined by expert speakers who discussed: 

  • An overview of the new GHSS, the five strategic directions, and the 2025 and 2030 targets.  
  • The progress countries have made to these goals and what needs to be done to achieve them.   
  • How community-based organisations and activists can use the GHSS and its targets for advocacy and to hold countries and health systems accountable to their commitments.  
  • Good practice examples of using the previous GHSS for advocacy and how countries have used GHSS in the planning and implementation of their national programmes.   

Watch it here ➡️


Chair: Danjuma Adda, President, World Hepatitis Alliance (WHA); and Executive Director, Center for Initiative and Development (CFID) and Chagro-Care Trust (CCT) 

Dr Olufunmilayo Lesi, Global HIV, Hepatitis and STIs Programmes Lead, World Health Organization (WHO) 

Devin Razavi-Shearer, Associate Director of hepatitis B, Center for Disease Analysis Foundation (CDAF) 

Honourable Éctor Jaime Ramírez Barba, MD and Member of Parliament, Mexico 

This webinar is supported by AbbVie.